Please use this identifier to cite or link to this item: http://ds.saudeindigena.icict.fiocruz.br/handle/bvs/6998
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpindel, R.-
dc.contributor.authorBaruzzi, R. G.-
dc.contributor.authorSouza, V. A. U. F.-
dc.contributor.authorFerreira, A. W.-
dc.contributor.authorAvila, S. L. M.-
dc.date.accessioned2022-06-02T12:28:18Z-
dc.date.available2022-06-02T12:28:18Z-
dc.date.issued2001-
dc.identifier.citationSPINDEL, R. ; et al. Measles vaccine coverage and immune response in children of Caiabi and Metuktire indian tribes living in malarial endemic area: Parque Indígena do Xingu, Central Brazil. Tropical Doctor, v. 31, n. 3, p. 142-144, 2001en_US
dc.identifier.issn0049-4755-
dc.identifier.urihttp://ds.saudeindigena.icict.fiocruz.br/handle/bvs/6998-
dc.language.isoengen_US
dc.publisherSAGE Publicationsen_US
dc.rightsopen accessen_US
dc.subject.otherMato Grossoen_US
dc.subject.otherRegião Amazônicaen_US
dc.subject.otherRegião Centro-Oesteen_US
dc.subject.otherParque Indígena do Xinguen_US
dc.subject.otherKaiabien_US
dc.subject.otherMetyktireen_US
dc.subject.otherMebêngôkre Kayapóen_US
dc.titleMeasles vaccine coverage and immune response in children of Caiabi and Metuktire indian tribes living in malarial endemic area: Parque Indígena do Xingu, Central Brazilen_US
dc.typeArticleen_US
dc.creator.affilliationEscola Paulista de Medicina. Departamento de Medicina Preventiva. Unidade de Saúde e Meio Ambiente. São Paulo, SP, Brasilen_US
dc.creator.affilliationEscola Paulista de Medicina. Departamento de Medicina Preventiva. Unidade de Saúde e Meio Ambiente. São Paulo, SP, Brasilen_US
dc.creator.affilliationUniversidade de São Paulo. Instituto de Medicina Tropical. São Paulo, SP, Brasilen_US
dc.creator.affilliationUniversidade de São Paulo. Instituto de Medicina Tropical. São Paulo, SP, Brasilen_US
dc.description.abstractenMeasles vaccination efficiency was evaluated in children from two Indian tribes ? Caiabi and Metuktire ? Living in the Amazon region, in the Parque Indígena do Xingu (PIX). The population sample, selected at random, made up 37 Caiabi and 28 Metuktire children, aged from 20?75 months (40%). For operational and epidemiological reasons, measles vaccine is given from 6 months of age. The average age of children when they received the vaccine was 11.5 months for the first dose and 20 months for the second. The search for IgG antibodies against measles virus and Plasmodium falciparum was made through immunofluorescence assay (IFA). Measles vaccine coverage has reached 60% at 12 months of age and 92% at 18 months, whereas post-vaccine serum conversion was 95% in Caiabi children (geometric mean of titres (GMT) 126) and 89% in Metuktire (GMT 109). The difference in GMT is not statistically significant.Seventy-three per cent of Caiabi children (GMT 101) and 100% of Metuktire children (GMT 135) were plasmodium antibody positive, showing they had been exposed to malarial infection. Despite the differences detected, the immune response to measles vaccine was satisfactory in both groups, with a positive percentage consistent with that achieved in non-malarial areas in Americas. The results show the efficiency of a vaccination programme in an indigenous area despite the difficulties in reaching the villages and maintaining the cold chain, and also despite the malaria endemicityen_US
dc.identifier.doi10.1177/004947550103100308-
dc.subject.decsBrasilen_US
dc.subject.decsÍndios Sul-Americanosen_US
dc.subject.decsSaúde de Populações Indígenasen_US
dc.subject.decsMaláriaen_US
dc.subject.decsSarampo/Imunologiaen_US
dc.subject.decsCobertura Vacinalen_US
dc.subject.decsSaúde da Criançaen_US
dc.subject.enBrazilen_US
dc.subject.enHealth of Indigenous Peoplesen_US
dc.subject.enIndians, South Americanen_US
dc.subject.enVaccination Coverageen_US
dc.subject.enMeaslesen_US
dc.subject.enMalariaen_US
dc.subject.enChild Healthen_US
Appears in Collections:DIP - Artigos de Periódicos



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.